← Back to Search

Intraoperative Echocardiography for Heart Disease

N/A

Waitlist Available

Led By Emily MacKay, DO

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥18 years

Scheduled to undergo isolated CABG surgery at PPMC

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 month

Awards & highlights

Study Summary

This trial aims to determine which CABG patients need TEE during surgery to improve outcomes.

Who is the study for?

This trial is for adults over 18 who are scheduled for low-risk isolated CABG surgery, have a good heart pump function (ejection fraction ≥50%), and recent heart tests. It's not for those with moderate or severe valve disease, planned aortic interventions, critical coronary disease, end-stage kidney disease on dialysis, certain esophageal conditions, or severe pulmonary hypertension.Check my eligibility

What is being tested?

The study aims to determine the usefulness of using an intraoperative TEE probe during CABG surgeries. The TEE probe is used to take detailed images of the heart from inside the esophagus during surgery to guide decisions and improve outcomes.See study design

What are the potential side effects?

While not explicitly stated in this summary, potential side effects of using a TEE probe may include sore throat, difficulty swallowing or rare complications like esophageal injury.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for a heart bypass surgery at PPMC.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Primary Objectives

Secondary outcome measures

Secondary Objectives

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: As-needed TEEExperimental Treatment1 Intervention

The TEE probe is placed only in situations where a surgeon requires information that can only be obtained by ultrasound imaging of the heart.

Group II: Default TEEActive Control1 Intervention

The TEE probe is placed after going under general anesthesia and a breathing tube is placed. TEE issued to take pictures of the heart before and after a CABG surgery. If randomized to this group, the TEE probe will remain in place throughout the surgery.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,048 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,499 Total Patients Enrolled

Emily MacKay, DOPrincipal InvestigatorUniversity of Pennsylvania, Penn Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment available for this experiment currently?

"According to clinicaltrials.gov, this particular medical trial is not currently enrolling patients as of yet; it was initially posted on February 1st 2024 and its content was most recently edited November 30th 2023. Nevertheless, the website lists 814 other trials that are seeking participants at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intraoperative Echocardiography in Low-Risk CABG Surgery

2024. "Intraoperative Echocardiography in Low-Risk CABG Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06154265.

All > Coronary Artery Disease